Luxfer (LXFR)
Supplies magnesium and zirconium alloys plus composite gas cylinders for defense and healthcare markets.
$17.27
vs last close+0.03 (+0.17%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Oct 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 97 | 96 | 89 | 100 | 99 | 103 | 97 | 104 | 93 | 91 | 84 | 96 |
| Cost of revenue | 83 | 79 | 71 | 78 | 77 | 81 | 76 | 80 | 71 | 69 | 62 | 71 |
| Gross profit | 15 | 17 | 18 | 22 | 22 | 23 | 21 | 24 | 22 | 22 | 22 | 25 |
| 14 | 28 | 14 | 18 | 5 | 19 | 14 | 14 | 12 | 14 | 13 | 17 | |
| Research & development | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| 11 | 12 | 12 | 12 | 11 | 13 | 13 | 13 | 11 | 13 | 11 | 12 | |
| Selling & marketing | 11 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 0 | 0 | 12 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other expenses | 2 | 15 | 1 | 5 | −7 | 5 | 0 | 0 | 0 | 0 | 0 | 3 |
| Operating income | 1 | −11 | 5 | 4 | 17 | 4 | 8 | 10 | 10 | 8 | 9 | 8 |
| −1 | −1 | −1 | −1 | −1 | 0 | 0 | −2 | −5 | −6 | −4 | −1 | |
| Interest expense | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | −1 | −1 | 2 | 4 | 6 | 3 | 0 |
| Income before tax | −1 | −13 | 4 | 3 | 16 | 4 | 7 | 7 | 5 | 2 | 6 | 7 |
| Income tax expense | 1 | −6 | 1 | 3 | 4 | 0 | 2 | 2 | 3 | 2 | 2 | 2 |
| Net income from continuing operations | −2 | −7 | 3 | 0 | 13 | 3 | 6 | 5 | 3 | 0 | 4 | 5 |
| Discontinued operations | 0 | 1 | 0 | 0 | 0 | 0 | 0 | −2 | 0 | −3 | 0 | 0 |
| Net income | −1 | −6 | 3 | −1 | 13 | 4 | 6 | 3 | 3 | −3 | 4 | 5 |
| EPS, basic | −$0.05 | −$0.22 | $0.10 | −$0.02 | $0.47 | $0.13 | $0.21 | $0.10 | $0.10 | −$0.12 | $0.14 | $0.18 |
| EPS, diluted | −$0.05 | −$0.22 | $0.10 | −$0.02 | $0.47 | $0.13 | $0.20 | $0.10 | $0.10 | −$0.12 | $0.13 | $0.18 |
| Weighted average shares, basic | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Weighted average shares, diluted | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| EBITDA | 4 | −8 | 8 | 8 | 18 | 11 | 11 | 12 | 9 | 6 | 9 | 8 |
| Depreciation & amortization | 3 | 3 | 2 | 4 | 1 | 6 | 3 | 3 | 3 | 3 | 3 | 0 |
| EBIT | 1 | −11 | 5 | 4 | 18 | 5 | 8 | 8 | 6 | 3 | 6 | 8 |